Reports for APOTEX INC
Company Name
APOTEX INC
Shortage reports
Actual shortage:
220 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
3124 (93%)
3354
Discontinuation Reports
To be discontinued:
25 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
367
146 (4%)
70 (29%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-07-25 | 2024-08-09 | 233700 |
| APO-PRUCALOPRIDE | 1MG | TABLET | Resolved | 2024-02-16 | 2024-03-29 | 219834 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-12-27 | 2020-10-24 | 70537 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-08-12 | 2020-09-04 | 122077 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-12 | 2020-09-04 | 122080 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-08-19 | 2020-09-04 | 122492 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2021-05-31 | 122495 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-19 | 2020-09-04 | 122497 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2020-11-19 | 2020-12-17 | 128618 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-04-05 | 2021-05-31 | 136811 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2017-09-04 | 2018-01-24 | 20888 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2017-09-27 | 2018-01-03 | 23635 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2017-10-18 | 2018-01-13 | 26195 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2017-11-01 | 2018-01-13 | 27735 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2018-02-01 | 2018-04-15 | 37974 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2018-02-01 | 2018-04-17 | 37977 |
| APO-QUETIAPINE | 300MG | TABLET | Resolved | 2018-02-01 | 2018-04-24 | 37980 |
| APO-QUETIAPINE | 200MG | TABLET | Resolved | 2018-02-13 | 2018-04-18 | 39669 |
| APO-QUETIAPINE | 25MG | TABLET | Resolved | 2021-04-30 | 2021-05-31 | 138352 |
| APO-QUETIAPINE | 100MG | TABLET | Resolved | 2021-05-14 | 2021-05-31 | 139416 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-BISACODYL | 5MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-09-07 | 2018-09-15 | 60288 |
| APO-BOSENTAN | 62.5MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71339 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71342 |
| APO-BOSENTAN | 125.0MG | TABLET | Discontinued | 2018-09-07 | 2018-10-31 | 60291 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2018-09-07 | 2018-12-28 | 60301 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | Discontinued | 2020-11-16 | 2020-11-16 | 128438 |
| APO-BRIMONIDINE | 0.2% | SOLUTION | To be discontinued | 2018-09-07 | 2018-09-07 | 60294 |
| APO-BROMAZEPAM - TAB 1.5MG | 1.5MG | TABLET | To be discontinued | 2018-09-07 | 2018-09-07 | 60304 |
| APO-BROMAZEPAM - TAB 3MG | 3MG | TABLET | Discontinued | 2018-09-07 | 2019-06-12 | 60307 |
| APO-BROMAZEPAM - TAB 6MG | 6MG | TABLET | Discontinued | 2018-09-07 | 2018-10-19 | 60310 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60313 |
| APO-CANDESARTAN | 16MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60316 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60325 |
| APO-CANDESARTAN | 8MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60322 |
| APO-CANDESARTAN | 4MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60319 |
| APO-CANDESARTAN | 32MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60328 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-09-07 | 2018-09-15 | 60331 |
| APO-CANDESARTAN/HCTZ | 25MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-05-03 | 41011 |
| APO-CANDESARTAN/HCTZ | 12.5MG 32MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41020 |
| APO-CANDESARTAN/HCTZ | 12.5MG 16.0MG | TABLET | Discontinued | 2018-02-26 | 2018-02-26 | 41047 |